期刊
ONCOGENE
卷 31, 期 1, 页码 27-38出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2011.209
关键词
miR-296; Scribble; cell plasticity; tumor progression; metastases
资金
- Doctorate School of Molecular Medicine at Universita degli Studi di Milano
- Fondazione Invernizzi
- Fondazione Berlucchi
- National Institutes of Health [HL54131, CA140043, CA78810, CA118005]
The expression of small, non-coding RNA or microRNAs (miR), is frequently deregulated in human cancer, but how these pathways affect disease progression is still largely elusive. Here, we report on a miR, miR-296, which is progressively lost during tumor progression and correlates with metastatic disease in colorectal, breast, lung, gastric, parathyroid, liver and bile ducts cancers. Functionally, miR-296 controls a global cell motility gene signature in epithelial cells by transcriptionally repressing the cell polarity-cell plasticity module, Scribble (Scrib). In turn, loss of miR-296 causes aberrantly increased and mislocalized Scrib in human tumors, resulting in exaggerated random cell migration and tumor cell invasiveness. Re-expression of miR-296 in MDA-MB231 cells inhibits tumor growth in vivo. Finally, miR-296 or Scrib levels predict tumor relapse in hepatocellular carcinoma patients. These data identify miR-296 as a global repressor of tumorigenicity and uncover a previously unexplored exploitation of Scrib in tumor progression in humans. Oncogene (2012) 31, 27-38; doi: 10.1038/onc.2011.209; published online 6 June 2011
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据